0       0

33rd Annual North American Cystic Fibrosis Conference


W23 - W23--CLIN: Current Issues in CF Pharmacotherapy


Nov 2, 2019 10:30am ‐ Nov 2, 2019 11:50am

Description

This session will focus on various CF pharmacotherapy issues facing practitioners today. The topics that will discussed are the standardization and improvement in the rate of Pseudomonas aeruginosa eradication, collaborative efforts of an integrated healthcare system CF team on medication delivery, analysis of tobramycin serum concentration monitoring strategies (central vs peripheral line collections), the impact of the addition of a dedicated-CF pharmacy technician to an ambulatory CF clinic team, and the evaluation of the impact of pharmacist-driven interventions on medication adherence and outcomes on CFTR modulator therapy.

Learning Objectives:

  • Describe the process involved to improve the rate of eradication of Pseudomonas aeruginosa.
  • Explain the impact of dedicated ambulatory CF pharmacy technicians and pharmacists on CF medication delivery, adherence, etc.
  • Discuss the difference in tobramycin serum concentration monitoring strategies between peripheral vein and central-line collections.

    Workshop Chair(s):

    Workshop Speaker(s):

    You must be logged in and own this session in order to post comments.

    Print Certificate
    Review Answers
    Print Transcript
    Completed on: token-completed_on
    Review Answers
    Please select the appropriate credit type:
    /
    test_id: 
    credits: 
    completed on: 
    rendered in: 
    * - Indicates answer is required.
    token-content
    token-speaker-name image
    token-speaker-name
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    /
    /
    token-index
    token-content